Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy.

Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes. Exp Dermatol (2005) 0.88

Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy. Mol Ther (2007) 0.80

Transgene-specific host responses in cutaneous gene therapy: the role of cells expressing the transgene. Gene Ther (2009) 0.79

Immune reactions in skin and hair follicle gene therapy. Mol Ther (2003) 0.75

Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest (2007) 1.56

Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev (2005) 1.36

Organization of stem cells and their progeny in human epidermis. J Invest Dermatol (2005) 1.23

Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol (2005) 1.13

Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol (2002) 0.95

Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Arch Dermatol (2002) 0.95

Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response. Clin Immunol (2003) 0.89

Lentivirus-mediated gene transfer to human epidermis. J Investig Dermatol Symp Proc (2004) 0.86

Aging of human epidermis: reversal of aging changes correlates with reversal of keratinocyte fas expression and apoptosis. J Gerontol A Biol Sci Med Sci (2004) 0.86

Fas pulls the trigger on psoriasis. Am J Pathol (2006) 0.82

Transduction of beta3 integrin subunit cDNA confers on human keratinocytes the ability to adhere to gelatin. Arch Dermatol Res (2006) 0.77

Skin equivalent and natural killer cells: a new model for psoriasis and GVHD. J Invest Dermatol (2008) 0.76

Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst (2005) 0.75